SSB 6287
In CommitteeSenate
Kratom products
Concerning the preparation, distribution, and sale of kratom products.
This status may be delayed. See Action History below for the latest updates.
How does a bill become law?
- Introduced: The bill is filed and assigned a number.
- Committee: A subject-matter committee holds hearings, takes public testimony, and decides whether to advance the bill.
- Floor Vote: The full chamber (House or Senate) debates and votes on the bill.
- Opposite Chamber: The bill repeats the committee and floor vote process in the other chamber.
- Governor: The Governor reviews the bill and decides whether to sign or veto it.
- Signed: The bill has been signed into law.
AI Analysis
This bill establishes new rules for kratom products in Washington, including safety standards, labeling requirements, and age restrictions. It bans certain harmful or synthetic additives, requires transparency about ingredients and potency, and gives local governments authority to impose stricter rules.
- Prohibits kratom processors and retailers from selling products that are mixed with harmful non-kratom substances, contain synthetic alkaloids, or exceed 2% 7-hydroxymitragynine in the alkaloid fraction.
- Requires all kratom products to be labeled with full ingredient list, percentages of mitragynine and 7-hydroxymitragynine, and the identity and address of the processor.
- Bars sale of kratom products to anyone under age 21.
- Makes violations of these rules a gross misdemeanor, and allows civil lawsuits for damages by aggrieved individuals.
- Allows cities and counties to adopt stricter local regulations on kratom than the state law.
Who is affected
- Kratom retailers and processors — Businesses that sell or distribute kratom products must comply with new labeling, ingredient, and age restrictions, and may face penalties for violations.
- Kratom consumers — Consumers gain access to safer, more transparent kratom products with standardized labeling and age restrictions, but must be at least 21 to purchase.
- Cities and counties in Washington — Local governments gain authority to impose stricter rules on kratom sales than the state law, allowing tailored local regulation.
- Kratom manufacturers and suppliers — Manufacturers and suppliers of kratom products must provide accurate ingredient and potency information to downstream sellers to avoid liability.
Pro/Con Analysis
Potential Benefits (5)
Banning harmful/non-kratom substances and synthetic alkaloids prevents dangerous adulteration (e.g., opioids, synthetic opioids, heavy metals) that has contributed to hospitalizations and deaths in unregulated markets.
Public SafetyPeopleRef: Sec. 3(1)(a)-(d)Age restriction to 21+ reduces youth access and potential long-term neurodevelopmental risks, consistent with evidence linking early exposure to psychoactive substances with increased addiction vulnerability.
Public SafetyPeopleRef: Sec. 3(2)Mandatory ingredient and potency labeling supports safer self-medication practices and helps clinicians and patients assess interactions—especially critical given kratom’s use for pain, anxiety, and opioid withdrawal.
HealthcarePeopleRef: Sec. 3(1)(e)Civil liability provision creates a direct enforcement mechanism for consumer harm,弥补ing gaps in regulatory enforcement and empowering individuals to hold bad actors accountable.
Rights & LibertiesLean peopleRef: Sec. 3(4)Local preemption authority allows communities to tailor rules to local needs (e.g., stricter controls near schools, bans in conservative jurisdictions), but may burden small businesses operating across municipal lines.
Local GovernmentRef: Sec. 3(5)
Potential Concerns (5)
Prohibiting harmful or synthetic additives and capping 7-hydroxymitragynine at 2% reduces risk of consumer injury, adverse health effects, and potential overdose—especially important given kratom’s unregulated status and variable potency in current market.
Public SafetyPeopleRef: Sec. 3(1)(a)-(d)Age restriction to 21+ aligns with federal and state standards for substances with potential for misuse or dependence (e.g., alcohol, tobacco, cannabis), limiting youth access and reducing early exposure risks to developing brains.
Public SafetyPeopleRef: Sec. 3(2)Mandatory labeling of full ingredients and alkaloid percentages (mitragynine/7-hydroxymitragynine) improves consumer transparency, enables informed decision-making, and supports harm reduction—especially for users managing chronic conditions or taking other medications.
HealthcarePeopleRef: Sec. 3(1)(e)Civil cause of action for damages empowers individuals harmed by violations (e.g., adulterated products, mislabeling) to seek redress, strengthening consumer protection and accountability.
Rights & LibertiesLean peopleRef: Sec. 3(4)Allowing local governments to impose stricter regulations respects regional differences in community values and public health priorities, but may create a patchwork of rules that complicate compliance for multi-jurisdictional vendors.
Local GovernmentRef: Sec. 3(5)
Who Is Most Affected
Retailers and processors face new compliance costs (labeling, testing, age verification), potential product reformulation, and liability exposure—but gain legal clarity and may benefit from reduced competition from unsafe or unlicensed vendors.
Consumers gain safer, transparent products and legal recourse for harm, but lose access to unregulated or higher-potency products and face age restrictions that may limit personal autonomy for some adults.
Local governments gain regulatory flexibility to address community concerns (e.g., youth access, public nuisance), but may face increased enforcement burdens and legal challenges to stricter ordinances.
Suppliers must provide accurate data to downstream sellers to avoid liability, incentivizing better supply chain oversight—but may face higher documentation and audit costs.